NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,776 | +0.9% | 3,905 | 0.0% | 0.29% | +4.6% |
| Q2 2023 | $394,066 | +10.0% | 3,905 | +0.3% | 0.28% | +4.9% |
| Q1 2023 | $358,082 | +4.2% | 3,892 | +2.7% | 0.27% | +0.8% |
| Q4 2022 | $343,731 | +19.4% | 3,789 | 0.0% | 0.26% | +14.2% |
| Q3 2022 | $288,000 | -10.0% | 3,789 | 0.0% | 0.23% | 0.0% |
| Q2 2022 | $320,000 | -4.8% | 3,789 | -1.1% | 0.23% | +22.1% |
| Q1 2022 | $336,000 | +2.8% | 3,832 | +2.5% | 0.19% | +9.2% |
| Q4 2021 | $327,000 | +6.9% | 3,738 | 0.0% | 0.17% | -3.3% |
| Q3 2021 | $306,000 | -10.3% | 3,738 | 0.0% | 0.18% | -5.3% |
| Q2 2021 | $341,000 | +7.2% | 3,738 | +0.3% | 0.19% | -3.1% |
| Q1 2021 | $318,000 | -53.6% | 3,725 | -48.8% | 0.20% | -20.0% |
| Q4 2020 | $686,000 | – | 7,274 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |